Frequently Asked Questions – Statement of Investigator (Form FDA 1572): Guidance for Sponsors, Clinical Investigators, and IRBs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Information Sheet
June 4, 2010
April 21, 2020
d997c3d8-2f5b-4be6-bdf5-3fcb57d6fe85
Related Documents
IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is Needed: Guidance for IRBs, Clinical Investigators, and Sponsors
Information SheetAugust 27, 2013Office of the Commissioner
IRB Continuing Review After Clinical Investigation Approval: Guidance for IRBs, Clinical Investigators, and Sponsors
Information SheetFebruary 27, 2012Office of the Commissioner
Codevelopment of Two or More New Investigational Drugs for Use in Combination
Information SheetJune 14, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.